Development and Validation of a Predictive Model for Metastatic Melanoma Patients Treated with Pembrolizumab Based on Automated Analysis of Whole-Body [F-18]FDG PET/CT Imaging and Clinical Features

Dirks, IneIneDirksKeyaerts, MarleenMarleenKeyaertsDirven, IrisIrisDirvenNeyns, BartBartNeynsVandemeulebroucke, JefJefVandemeulebroucke2023-10-172023-09-262023-10-1720232072-6694WOS:001057686200001https://imec-publications.be/handle/20.500.12860/42588Development and Validation of a Predictive Model for Metastatic Melanoma Patients Treated with Pembrolizumab Based on Automated Analysis of Whole-Body [F-18]FDG PET/CT Imaging and Clinical FeaturesJournal article10.3390/cancers15164083WOS:001057686200001LIGAND 1 EXPRESSIONSURVIVALOUTCOMESDISCONTINUATIONTHERAPYAREASMEDLINE:37627111